If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
211.00    -2.00 (-0.94%)
Bid:
209.00
Ask:
210.00
Spread: 1.00 (0.478%)
Market Cap: £583.24m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Statement under s. 430(2B) Companies Act 2006

23 Dec 2014 14:00

RNS Number : 6114A
Morgan Advanced Materials PLC
23 December 2014
 



23 December 2014

Morgan Advanced Materials plc ("the Company")

The Company makes the following statement in accordance with section 430 (2B) of the Companies Act 2006:

Mark Robertshaw

Further to the announcements on 29 September 2014 and 12 December 2014 that Mark Robertshaw, Chief Executive Officer, will step down as a Director and leave the Company on 31 December 2014, the following arrangements will apply in respect of Mark Robertshaw's remuneration:

1. Mark Robertshaw will receive his salary up until 31 December 2014.

 

2. The Remuneration Committee has agreed to treat Mark Robertshaw as a 'good leaver', in recognition of his significant contribution to re-shaping Morgan over the past eight years, improving the resilience and quality of the Group and leaving a strong legacy for the future.

 

3. In accordance with the terms of the annual bonus, Mark Robertshaw will remain eligible for a bonus in respect of the full 2014 financial year, subject to achievement of the performance conditions.

 

4. Long-term incentives: Awards outstanding at the time of leaving will remain subject to the terms of the relevant plan rules.

 

Long-Term Incentive Plan ("LTIP"): 2013 and 2014 LTIP awards will be pro‑rated for time served since the commencement of the three-year performance period. All outstanding awards will vest on the normal vesting date subject to the achievement of performance conditions attaching to the awards over the full performance period.

 

Date of Award

End of three-year performance period

Pro-rated no. of shares under award (still subject to performance conditions)

Vesting Date

27 February 2012

31 December 2014

134,907*

27 February 2015

20 May 2013

31 December 2015

114,671

20 May 2016

28 February 2014

31 December 2016

58,521

28 February 2017

* award not pro-rated as Mark Robertshaw was in post for the duration of the performance period

 

Bonus Deferral Share Matching Plan ("BDSMP"): The only BDSMP award outstanding at 31 December 2014 was granted on 21 March 2012. On the normal vesting date (21 March 2015), 76,772 Investment Shares (including notional dividends accrued) will automatically be released to Mark Robertshaw, subject to withholding for income tax and NICs. Additionally, up to 230,324 shares awarded under the corresponding BDSMP Matching Award may be released on the normal vesting date, subject to the extent to which the EPS performance condition is achieved. This award is not subject to time pro‑rating as Mark Robertshaw was in post for the duration of the three-year performance period.

 

These arrangements are in line with the Remuneration Policy approved by shareholders at the 2014 AGM. Details of the actual payments made will be disclosed in the relevant Directors' Remuneration Report.

 

 

Further enquiries:

Paul Boulton, Company Secretary Morgan Advanced Materials 01753 837000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEAFDDFLSEIE
Date   Source Headline
1st Jun 20264:35 pmRNSDirector/PDMR Shareholding
28th May 202610:10 amRNSHolding(s) in Company
26th May 20265:21 pmRNSDirector/PDMR Shareholding
18th May 20262:53 pmRNSHolding(s) in Company
13th May 20265:26 pmRNSHolding(s) in Company
12th May 20262:09 pmRNSDirector/PDMR Shareholding
7th May 20261:19 pmRNSResult of AGM
7th May 20267:00 amRNSCFO Intention to retire
7th May 20267:00 amRNSAGM Trading Update
29th Apr 20264:23 pmRNSDirector/PDMR Shareholding
9th Apr 20263:51 pmRNSHolding(s) in Company
31st Mar 20261:16 pmRNSDirector/PDMR Shareholding
26th Mar 20265:39 pmRNSDirector/PDMR Shareholding
26th Mar 20269:53 amRNSAnnual Financial Report
24th Mar 20262:44 pmRNSDirector/PDMR Shareholding
9th Mar 20269:34 amRNSDirector/PDMR Shareholding
5th Mar 20269:30 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSFull Year Results
23rd Feb 20269:00 amRNSHolding(s) in Company
2nd Feb 20264:12 pmRNSTotal Voting Rights
2nd Feb 20269:30 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202611:57 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.